Production, purification and analysis of an experimental DNA vaccine against rabies

Journal of Gene Medicine

Volumn 3, Issue 6, 2001, Pages 577-584

  Diogo, Maria M ^a   Ribeiro, Sofia C ^a   Queiroz, João A ^b   Monteiro, Gabriel A ^a   Tordo, Noel ^c   Perrin, Pierre ^c   Prazeres, Duarte M F ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^c INSTITUT PASTEUR   (France)

Author keywords

DNA vaccine; Glycoprotein; Hydrophobic interaction chromatography; Plasmid; Protection; Rabies

Indexed keywords

ESCHERICHIA COLI; LIMULUS; LIMULUS AMOEBOCYTE; RABIES VIRUS;

DNA VACCINE; GLYCOPROTEIN; RABIES VACCINE; VIRUS ANTIBODY; VIRUS PROTEIN;

AGAR GEL ELECTROPHORESIS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; FEMALE; GENE VECTOR; GENETIC TRANSFORMATION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; KINETICS; MOUSE; PLASMID; RABIES; RABIES VIRUS; TIME;

ANIMALS; ANTIBODIES, VIRAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, AGAR GEL; FEMALE; GENETIC VECTORS; GLYCOPROTEINS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENTRICULAR; KINETICS; MICE; MICE, INBRED BALB C; PLASMIDS; RABIES; RABIES VACCINES; RABIES VIRUS; TIME FACTORS; TRANSFORMATION, GENETIC; TUMOR CELLS, CULTURED; VACCINES, DNA; VIRAL PROTEINS;

EID: 0035523565     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.218     Document Type: Article

References (20)

1. Tighe H, Corr M, Roman M, Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 1998; 19: 89-97.
2. Le TP, Coonan KM, Hedstrom TC, et al. Safety, tolerability, and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 2000; 18: 1893-1901.
3. Fomsgaard A. HIV-1 DNA vaccines. Immunol Lett 1999; 65: 127-131.
4. van Drunen Little-van den Hurk S, Braun RP, Babiuk LA. Veterinary DNA vaccines. In DNA Vaccines: Methods and Protocols, Lowrie DB, Whalen RG (eds). Humana Press: Totowa, 2000; 79-94.
5. CBER/FDA. Points to Consider on Plasmid DNA Vaccines for Preventive Infectious Disease Indications. CBER/FDA: Bethesda, 1997.
6. CPMP. Note for Guidance on the Quality, Preclinical and Clinical Aspects of Gene Transfer Medicinal Products, CPMP/BWP/3088/99, London, 1999.
7. Diogo MM, Ribeiro S, Queiroz JA, et al. Scale-up of hydrophobic interaction chromatography for the purification of a DNA vaccine against rabies. Biotechnol Lett 2000; 22: 1397-1400.
8. Meslin FX, Fishbein D, Matter H. Rationale and prospects for rabies elimination in developing countries. In Lyssaviruses, Rupprecht C (ed.). Springer: Berlin, 1994; 1-26.
9. Perrin P, Jacob Y, Tordo N. DNA-based immunization against Lyssaviruses. Intervirology 2001; 43: 302-311.
10. Perrin P, Jacob Y, Aguilar-Setien A, et al. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine 2000; 18: 479-186.
11. Bahloul C, Jacob Y, Tordo N, Perrin P. DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine 1998; 16: 417-425.
12. Jallet C, Jacob Y, Bahloul C, et al. Chimeric lyssavirus glycoproteins with increased immunological potential. J Virol 1999; 73: 225-233.
13. Desmézières E, Jacob Y, Saron M-F, Delpeyroux F, Tordo N, Perrin P. Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines. J Gen Virol 1999; 80: 2343-2351.
14. Diogo MM, Queiroz JA, Monteiro GA, Ferreira GNM, Martins SAM, Prazeres DMF. Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography. Biotechnol Bioeng 2000; 68: 576-583.
15. Sambrook J, Fritisch EF, Maniatis T. Molecular Cloning: a Laboratory Manual (2nd edn). Cold Spring Harbor Laboratory Press: New York, 1989.
16. Sundberg L, Porath J. Preparation of adsorbents for biospecific affinity chromatography. I. Attachment of group-containing ligands to insoluble polymers by means of bifunctional oxiranes. J Chromatogr 1974; 90: 87-98.
17. Smith J, Yager P, Baer G. A rapid fluorescent focus inhibition test (RFFIT) for determining virus-neutralizing antibody. In Laboratory Techniques in Rabies (4th edn), Meslin F-X, Kaplan M, Koprowski H (eds). World Health Organisation: Geneva, 1996; 181.
18. Perrin P, Versmisse P, Delagneau JF, Lucas G, Rollin P, Sureau P. The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus. J Biol Standard 1986; 14: 95-102.
19. Horn NA, Meek JA, Budahazi G, Marquet M. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum Gene Ther 1995; 6: 565-573.
20. Wilbur L, Aubert M. The NIH test for potency. In Laboratory Techniques in Rabies (4th edn), Meslin F-X, Kaplan M, Koprowski H (eds). World Health Organisation: Geneva, 1996; 360-368.